Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-02

Clinical Trial Update: ELIRA 2: Safety and Effectiveness of TENS Assisted Weight Loss and Appetite Suppression [NA]

View source ↗

Summary

A completed clinical trial update on ELIRA 2 assessing safety and effectiveness of TENS-assisted weight loss and appetite suppression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TENS-assisted weight loss therapy

Snippet

Sponsor: Elira Therapeutics, Inc. | Conditions: Weight Loss | NA | Status: COMPLETED | Results posted: 2022-02-02